QIC BioStream Installation at the University of Queensland
June 26, 2023
Jim Melling recently visited the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland to install a QIC BioStream with 80-way Proteus valve. The team at AIBN are working with the ARC Centre of Excellence in Synthetic Biology to design and construct novel biological systems that can convert biomass from agriculture or waste streams to biofuel, [...]
Waters Corporation and Princeton University Announce Multi-Year Research Collaboration
June 26, 2023
News Summary: Waters and Princeton University signed a multi-year agreement to take on real-world challenges in biologics and materials research. Initial collaboration will bring together Waters scientists with Princeton faculty and students to advance research in drug discovery and development using novel bioseparation techniques. Additional joint research areas may include higher purity pharmaceuticals, advanced analytical [...]
Biotium Introduces Novel Antibody Labeling Kits for Rapid and Efficient Labeling of IgM Antibodies
June 26, 2023
Mix-n-Stain™ CF® Dye IgM Antibody Labeling Kits address longstanding challenges for labeling IgM antibodies by offering efficient and convenient conjugation with bright CF® Dyes Fremont, CA, June 26, 2023 – Life Science Newswire – Biotium, a leading provider of innovative life science solutions, is thrilled to announce the release of its latest product, Mix-n-Stain™ CF® [...]
June 26, 2023
HALIFAX, Nova Scotia - 3DBioFibR, a leading innovator in tissue engineering, announced today it is launching two new collagen fiber products, μCollaFibR™ (pronounced micro-CollaFibR™) and CollaFibR™ 3D scaffold. Made using 3D BioFibR’s proprietary and new dry-spinning technology to create collagen fibers at commercial scales, these off-the-shelf products offer significant advantages for tissue engineering and tissue [...]
June 26, 2023
Laboratory will enable visualization of biological molecules in unprecedented detail and at scale, providing the company with a competitive advantage in the de novo therapeutic protein field SOMERVILLE, Mass. – Generate:Biomedicines today announced the unveiling of its cryogenic electron microscopy (CryoEM) laboratory in Andover, Massachusetts. Among the largest privately-owned CryoEM laboratories in the United States, this 70,000 sq ft site will enable [...]
June 26, 2023
Chip-A1 allows researchers to effectively model complex 3D tissues, such as the tumor microenvironment and skin, with direct compound dosing capabilities. Boston, MA – Emulate, Inc., the leading provider of next-generation in vitro models, today announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program. This new Organ-Chip design expands on the original [...]
June 26, 2023
CHENGDU, China -- HitGen Inc. ("HitGen", SSE: 688222.SH) has recently launched a newly upgraded version of its OpenDEL™ product, a self-service screening kit for novel molecules. It contains 65% more DEL libraries than the previous version, and with over 3 billion compounds. The 2-cycle and 3-cycle libraries in the kit are designed with excellent drug-like properties. [...]
June 26, 2023
Mirna Jarosz, formerly General Manager of Integrated DNA Technology's (IDT) NGS business will focus on driving customer success, strategy and commercial focus as Head of Product Strategy Shlomey Derhi, former head of R&D for a large group within the Israel Defense Forces will focus on accelerating technology development as Head of Architecture and Integration FREMONT, [...]
June 26, 2023
Peabody and Andover, MA - Two towering JEOL Electron Microscopes stand ready to produce terabytes of valuable data for researchers at Generate:Biomedicines each day, who are accelerating drug discovery and development of novel therapeutics using machine learning and generative artificial intelligence. The two Transmission Electron Microscopes, the JEOL CRYO ARM 200 and CRYO ARM 300 [...]
June 26, 2023
Agreements with Vizgen, Resolve Biosciences, and Ultivue expand end-to-end, large-scale, deep molecular profiling and custom data analytics services offering LEUVEN, Belgium -- OMAPiX, a leading provider of spatial omics services and custom data analytics, today announced strategic partnerships with Vizgen, Inc., Resolve Biosciences, and Ultivue, Inc. As part of the agreements, OMAPiX scientists will use [...]

